Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Pathology|September 27, 2024
Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoidClara Domingo-Sabugo, Saffron Ag Willis-Owen, Amit Mandal, et al.
Diabetologia|October 8, 2020
Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cellsMatthew B Johnson, Kashyap A Patel, Elisa De Franco, et al.
Cancer Research Communications|February 24, 2023
Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with CancerDuncan R McKenzie, Rosalind Graham, Thomas Lechmere, et al.
Immunotherapy Advances|January 24, 2022
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetesAshish K Marwaha, Samuel Chow, Anne M Pesenacker, et al.
Ebiomedicine|March 6, 2019
Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samplesSofia Christakoudi, Manohursingh Runglall, Paula Mobillo, et al.
The Lancet. Rheumatology|November 15, 2021
Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
The Lancet. Rheumatology|July 14, 2021
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
Nature Medicine|July 30, 2024
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trialDanijela Tatovic, Ashish Marwaha, Peter Taylor, et al.
The Journal of Experimental Medicine|April 18, 2024
Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiencyMatthew B Johnson, Masato Ogishi, Clara Domingo-Vila, et al.
The Lancet. Oncology|April 30, 2021
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational studyLeticia Monin, Adam G Laing, Miguel Muñoz-Ruiz, et al.
Pageof 3